Filing Details

Accession Number:
0001181431-13-063423
Form Type:
4
Zero Holdings:
No
Publication Time:
2013-12-18 17:27:14
Reporting Period:
2013-12-16
Filing Date:
2013-12-18
Accepted Time:
2013-12-18 17:27:14
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1070336 Achillion Pharmaceuticals Inc ACHN Pharmaceutical Preparations (2834) 000000000
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1290166 Qvt Associates Gp Llc 1177 Avenue Of The Americas
9Th Floor
New York NY 10036
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock, $0.001 Par Value Disposition 2013-12-16 50,647 $3.13 11,662,306 No 4 S Indirect Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P.
Common Stock, $0.001 Par Value Disposition 2013-12-17 42,156 $3.08 11,620,150 No 4 S Indirect Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Indirect Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P.
No 4 S Indirect Through QVT Fund IV LP, QVT Fund V LP and Quintessence Fund L.P.